In addition, it has been reported that in lung cancer, the removal of N-glycans from PD-L1 significantly increases the detection efficiency of commercially available PD-L1 antibodies, such as 28 − 8, CAL10, and SP142 [91]. Here, CD274 is linked to lung cancer.